Literature DB >> 9183303

Interrelationships between weight loss, body fat distribution and sex hormones in pre- and postmenopausal obese women.

E Turcato1, M Zamboni, G De Pergola, F Armellini, A Zivelonghi, I A Bergamo-Andreis, R Giorgino, O Bosello.   

Abstract

OBJECTIVES: Relationships between regional body fat distribution and sex hormones as well as changes in sex hormones after weight loss were evaluated.
SETTING: All subjects were hospitalized in the Institute of Internal Medicine of the University of Verona.
SUBJECTS: Twenty-six premenopausal (age 33.7 +/- 10.2 years) and 15 postmenopausal (age 57.9 +/- 5.9 years) obese women.
INTERVENTIONS: Body weight, body-mass index, waist and hip circumferences, visceral fat by computed tomography and sex hormones were evaluated before and after 4 weeks on a very low energy diet.
RESULTS: Body-mass index was higher in pre-than in postmenopausal women, although the difference was not significant. Total and free testosterone were significantly higher in the pre- than in the postmenopausal group (P < 0.001). Significant negative correlations were found between age and total testosterone (r = -0.65; P < 0.001), free testosterone (r = -0.54; P < 0.001), androstenedione (r = -0.46; P < 0.01) and urinary cortisol excretion (r = -0.50; P < 0.01). A negative correlation was found between visceral fat and total testosterone (r = -0.41; P < 0.01). After adjusting for age, the negative correlation between total testosterone and visceral fat encountered both in the subject group as a whole and in premenopausal women was no longer significant, whilst a significant negative association between visceral fat and sex hormone binding globulin (SHBG) (r = -0.56; P < 0.001) was always found. When step-down regression analysis was used to evaluate the joint effect of age, menopausal status, and anthropometric and metabolic variables on sex hormones, age was the most powerful independent variable for predicting total testosterone, free testosterone and androstenedione levels, whilst menopausal status was the most powerful predictor of FSH and LH levels. Changes in hormones after VLED were analysed separately in pre- and postmenopausal women. None of the hormones changed significantly after VLED in the postmenopausal group, except for FSH values. LH, free testosterone and urinary cortisol excretion values decreased significantly after VLED in the premenopausal group.
CONCLUSIONS: Our data show that age, to a greater extent than visceral fat, seems to be negatively associated with steroid sex hormones. Weight loss seems to be associated with changes in sex hormones only in premenopausal women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183303     DOI: 10.1046/j.1365-2796.1997.120129000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

Review 1.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial.

Authors:  Kristin L Campbell; Karen E Foster-Schubert; Catherine M Alfano; Chia-Chi Wang; Ching-Yun Wang; Catherine R Duggan; Caitlin Mason; Ikuyo Imayama; Angela Kong; Liren Xiao; Carolyn E Bain; George L Blackburn; Frank Z Stanczyk; Anne McTiernan
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

Review 3.  A review of the relationships between extreme obesity, quality of life, and sexual function.

Authors:  David B Sarwer; Megan Lavery; Jacqueline C Spitzer
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

4.  Adult weight change and incidence of premenopausal breast cancer.

Authors:  Karin B Michels; Kathryn L Terry; A Heather Eliassen; Susan E Hankinson; Walter C Willett
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

5.  4-Year Changes in Sex Hormones, Sexual Functioning, and Psychosocial Status in Women Who Underwent Bariatric Surgery.

Authors:  David B Sarwer; Thomas A Wadden; Jacqueline C Spitzer; James E Mitchell; Kathy Lancaster; Anita Courcoulas; William Gourash; Raymond C Rosen; Nicholas J Christian
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

6.  Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.

Authors:  Eric S Freedland
Journal:  Nutr Metab (Lond)       Date:  2004-11-05       Impact factor: 4.169

7.  Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women.

Authors:  Agnieszka Olszanecka; Kalina Kawecka-Jaszcz; Danuta Czarnecka
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

8.  The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.

Authors:  M N Harvie; M Pegington; M P Mattson; J Frystyk; B Dillon; G Evans; J Cuzick; S A Jebb; B Martin; R G Cutler; T G Son; S Maudsley; O D Carlson; J M Egan; A Flyvbjerg; A Howell
Journal:  Int J Obes (Lond)       Date:  2010-10-05       Impact factor: 5.095

9.  Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.

Authors:  Rachael Z Stolzenberg-Solomon; Roni T Falk; Frank Stanczyk; Robert N Hoover; Lawrence J Appel; Jamy D Ard; Bryan C Batch; Janelle Coughlin; Xu Han; Lillian F Lien; Christina M Pinkston; Laura P Svetkey; Hormuzd A Katki
Journal:  Breast Cancer Res       Date:  2012-10-31       Impact factor: 6.466

10.  Associations between body shape across the life course and adulthood concentrations of sex hormones in men and pre- and postmenopausal women: a multicohort study.

Authors:  Ya-Wen Chen; Dong Hang; Ane S Kværner; Edward Giovannucci; Mingyang Song
Journal:  Br J Nutr       Date:  2021-06-30       Impact factor: 4.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.